Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2024/08/01/moderna-stock-gaps-lower-after-earnings

8/1/2024 10:37 AM

Moderna Inc (NASDAQ:MRNA) stock is freefalling this morning, last seen down 15.2% to trade at $95.48 and pacing for its worst day since November 2021 after the company's second-quarter financial resul...

3 Biotech Stocks to Monitor Right Now

https://www.schaeffersresearch.com/content/news/2024/06/10/3-biotech-stocks-to-monitor-right-now

6/10/2024 3:33 PM

Last week, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month. Going off of that, we're profiling XBI's three biggest holdings, Novavax Inc (...

Stocks Look to Close Short Week With Monthly, Quarterly Wins

https://www.schaeffersresearch.com/content/news/2024/03/28/stocks-look-to-close-short-week-with-monthly-quarterly-wins

3/28/2024 12:13 PM

Volatility plagued stocks during the holiday-shortened week, which also ushered the end of March and first quarter. Much of the optimism surrounding potential interest rate cuts faded, with the Do...

Moderna Stock Pops After Acquiring Millions in Funding

https://www.schaeffersresearch.com/content/news/2024/03/27/moderna-stock-pops-after-acquiring-millions-in-funding

3/27/2024 2:29 PM

Moderna Inc (NASDAQ:MRNA) is 1.8% higher to trade at $109.29 at last check, after the company received $750 million in funding from Blackstone Life Sciences (BX) to develop mRNA flu vaccines. For th...

Stocks Look to Score Winning Week After Shaky Start

https://www.schaeffersresearch.com/content/news/2024/02/23/breaking-down-wall-streets-mixed-tune-week

2/23/2024 1:27 PM

The holiday-shortened week got off on the wrong foot, as tech investors took profits ahead of Nvidia's (NVDA) highly anticipated earnings report. Additionally, sour sentiment from the Federal Rese...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity